Evidence map›Paper›PMID 25492117›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2015

Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration.

Jeffrey J Lochhead, Daniel J Wolak, Michelle E Pizzo, Robert G Thorne

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 3 pooled it
7.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 3 syntheses or guidelines pooled it, 252 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review.International journal of molecular sciences · 2021
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Nose-to-brain drug delivery: A new frontier in targeted therapeutics.Iranian journal of basic medical sciences · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Olfactory Drug Delivery in Rodents: Deposition and Pharmacokinetics.ACS pharmacology & translational science · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Optimization of Glyburide-loaded NanosuspensionsCurrent pharmaceutical design · 2025
    Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeffrey J LochheadDivision of Pharmaceutical Sciences, University of Wisconsin-Madison School of Pharmacy, Madison, Wisconsin, USA.
Daniel J Wolak1] Division of Pharmaceutical Sciences, University of Wisconsin-Madison School of Pharmacy, Madison, Wisconsin, USA [2] Clinical Neuroengineering Training Program, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Michelle E Pizzo1] Division of Pharmaceutical Sciences, University of Wisconsin-Madison School of Pharmacy, Madison, Wisconsin, USA [2] Clinical Neuroengineering Training Program, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Robert G Thorne1] Division of Pharmaceutical Sciences, University of Wisconsin-Madison School of Pharmacy, Madison, Wisconsin, USA [2] Clinical Neuroengineering Training Program, University of Wisconsin-Madison, Madison, Wisconsin, USA [3] Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin, USA [4] Cellular and Molecular Pathology Training Program, University of Wisconsin-Madison, Madison, Wisconsin, USA [5] The Institute for Clinical and Translational Research, University of Wisconsin-Madison, Madison, Wisconsin, USA.
University of Wisconsin–Madison · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
Wisconsin Alzheimer's Disease Research CenterP50AG033514 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI JOHNSON, STERLING C · 2009 to 2018
$16.2M
Institutional Clinical and Translational Science AwardKL2TR000428 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$6.2M
Clinical Neuroengineering Training ProgramT32EB011434 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI MEYERAND, MARY E., PEARCE, ROBERT A · 2011 to 2015
$869k
NCATS NIH HHS KL2 TR000428NCATS NIH HHS KL2TR00428NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1TR000427NIA NIH HHS P50 AG033514NIA NIH HHS P50-AG033514NIBIB NIH HHS T32 EB011434
6 · The paper itself

Abstract

The intranasal administration route is increasingly being used as a noninvasive method to bypass the blood-brain barrier because evidence suggests small fractions of nasally applied macromolecules may reach the brain directly via olfactory and trigeminal nerve components present in the nasal mucosa. Upon reaching the olfactory bulb (olfactory pathway) or brainstem (trigeminal pathway), intranasally delivered macromolecules appear to rapidly distribute within the brains of rodents and primates. The mechanisms responsible for this distribution have yet to be fully characterized. Here, we have used ex vivo fluorescence imaging to show that bulk flow within the perivascular space (PVS) of cerebral blood vessels contributes to the rapid central distribution of fluorescently labeled 3 and 10 kDa dextran tracers after intranasal administration in anesthetized adult rats. Comparison of tracer plasma levels and fluorescent signal distribution associated with the PVS of surface arteries and internal cerebral vessels showed that the intranasal route results in unique central access to the PVS not observed after matched intravascular dosing in separate animals. Intranasal targeting to the PVS was tracer size dependent and could be regulated by modifying nasal epithelial permeability. These results suggest cerebral perivascular convection likely has a key role in intranasal drug delivery to the brain.

Indexed as

Administration, IntranasalAnimalsBlood-Brain BarrierBrainEnzyme-Linked Immunosorbent AssayFemaleFluorescent Antibody TechniqueFluorescent DyesMatrix Metalloproteinase 9Microscopy, ConfocalOptical ImagingRatsRats, Sprague-DawleyFluorescent DyesMatrix Metalloproteinase 9

Identifiers

PMID25492117
PMCPMC4348383
OpenAlexW1999116330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.